The Sunshine Act: With Open Payments Now Live, What this Means for Your Compliance Program and Your Relationships with HCPs, Both Here and Abroad

March 12, 2015 4:30pm

Jodie Sherman Gillon
Head, External Interface Office
AstraZeneca

Danielle Gallo
Senior Analyst, Global Transparency Reporting
Becton, Dickinson and Company

  • Six months after Open Payments goes live, how the industry is managing it, and how the public is responding
  • Knowing your vulnerabilities and identifying data points and outliners which may signal a broader problem
  • Creating QA/QC checks and controls in place at every stage to make sure the data is being categorized and reported correctly
  • As more companies expand globally, what are the requirements for reporting and transparency in in Japan, Latin America, Europe, and Slovakia?
    • In light of past FCPA cases, is it worth globalizing your domestic transparency systems in anticipation of future domestic demands as well as those imposed by non-U.S. regulators?
  • After over a year of reporting, how the Sunshine Act has affected relationships with providers and what lessons can be gleaned to maintain those relationships moving forward